Feedback / Questions
ADI-001 - Adicet Bio
https://www.businesswire.com/news/home/20241118011893/en/Adicet-Bio-Announces-First-Lupus-Nephritis-Patient-Dosed-in-Phase-1-Clinical-Trial-of-ADI-001-in-Autoimmune-Diseases
Nov 18, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next